Breast Cancer Episode 24: Olaparib as a treatment option in germline BRCA-mutated, HER2- metastatic breast cancer: the OlympiAD trial 2 May 2024
Breast Cancer Episode 23: ESMO clinical practice guidelines for early-stage breast cancer 25 April 2024
Breast Cancer Episode 22: Neoadjuvant and adjuvant pembrolizumab in early-stage high-risk ER+/HER2- breast cancer: KEYNOTE-756 18 April 2024
Breast Cancer Episode 21: Neoadjuvant immunotherapy for high-risk ER+/HER2- breast cancer: insights from the CheckMate-7FL trial 28 March 2024
Breast Cancer Episode 20: Primary results from the TROPION-Breast01 study on Dato-DXd in HR+/HER2- metastatic breast cancer treatment 21 March 2024
Breast Cancer Episode 19: Efficacy of ADC therapy in HER2 low breast cancer: updated results from DESTINY-Breast04 14 March 2024
Breast Cancer Episode 18: Olaparib increases ORR in advanced cancers with BRCA1/2 but not CHEK2 and ATM mutations, the PRECISION 2 trial 7 March 2024
Breast Cancer Episode 17: Insights from the KATHERINE Trial: iDFS surrogate endpoint is predictive for OS in breast cancer patients 29 February 2024
Breast Cancer Episode 16: The NATALEE trial: ribociclib as a key adjuvant CDK4/6 Inhibitor for breast cancer 22 February 2024
Breast Cancer Episode 15: 5-Year Follow-Up of Abemaciclib Plus Endocrine Therapy in High-Risk HR+/HER2- Early Breast Cancer – Insights from the MonarchE Study 15 February 2024
